aminolevulinic acid HCL (ALA)

DRUG2 trials

Sponsors

DUSA Pharmaceuticals, Inc., Nathalie Zeitouni

Conditions

Acne VulgarisBasal Cell Carcinoma (BCC)

Phase 1

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

RecruitingNCT06623201

Nathalie ZeitouniBasal Cell Carcinoma (BCC)

Start: 2024-10-07End: 2026-12-01Target: 20Updated: 2026-01-29

Phase 2

Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne

CompletedNCT00706433

DUSA Pharmaceuticals, Inc.Acne Vulgaris

Start: 2007-03-31End: 2008-07-31Updated: 2011-10-24